Home > Haematology > New guideline helps patients and parents navigate pediatric acute lymphoblastic leukemia

New guideline helps patients and parents navigate pediatric acute lymphoblastic leukemia


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
National Comprehensive Cancer Network
Reuters Health - 07/10/2020 - A new guideline from the National Comprehensive Cancer Network (NCCN) provides information about pediatric acute lymphoblastic leukemia (ALL) to patients and their families in an easy-to-learn format. The guideline, based on the NCCN Guidelines for Pediatric ALL addressed to clinicians, covers the basics of ALL and all aspects of its testing and treatment. It is available from the NCCN's website (https://bit.ly/36E7FOu). The diagnosis of ALL relies on bone-marrow biopsy, but numerous other tests are necessary to check for signs of disease and how well the organs are working. These can include blood tests, spinal fluid tests, and imaging that could include CT, MRI and/or PET scan. Genetic testing can be used to identify specific changes associated with ALL, and some of these mutations can be targeted with specific therapies. Not all mutations are inherited from parents; some develop spontaneously. Treatment for pediatric AL...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on